Revista internacional de investigación y desarrollo en farmacia y ciencias biológicas

Abstracto

Revolutionizing Oncological Interventions: Unveiling the Paradigm Shift of Target Cancer Therapies

Dr. Anubhav Chaurasia

This review article explores the transformative impact of targeted cancer therapies, revolutionizing the field of oncological interventions. Emphasizing precision and specificity, targeted therapies selectively attack cancer cells while minimizing harm to healthy tissues. Various modalities, including small molecule inhibitors, monoclonal antibodies, and immune checkpoint inhibitors, are discussed, along with their distinct mechanisms of action. The review highlights clinical successes, challenges of resistance, and the role of predictive biomarkers in personalized medicine. Furthermore, the potential synergies of targeted agents with traditional therapies and emerging prospects in drug delivery systems and gene editing approaches are examined. Targeted cancer therapies represent a paradigm shift in cancer treatment, enhancing patient outcomes and reshaping oncology.